RAPT Therapeutics, Inc. Profile Avatar - Palmy Investing

RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead infl…

Biotechnology
US, South San Francisco [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of RAPT's Analysis
CIK: 1673772 CUSIP: 75382E109 ISIN: US75382E1091 LEI: - UEI: -
Secondary Listings
RAPT has no secondary listings inside our databases.